Capturing the patient experience in systemic lupus erythematosus: Are widely used measures fit-for-purpose and adherent to FDA PRO guidance recommendations?

Majercak, Kayleigh R; Perfetto, Eleanor M; Villalonga-Olives, Ester

Majercak, Kayleigh R; Perfetto, Eleanor M; Villalonga-Olives, Ester.

Afiliación

Majercak KR; Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, 220 Arch Street, 12th Floor, Baltimore, MD, 21201, USA.
Perfetto EM; Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland Baltimore, 220 Arch Street, 12th Floor, Baltimore, MD, 21201, USA.
Villalonga-Olives E; National Health Council, Washington, DC, USA.

J Patient Rep Outcomes ; 6(1): 7, 2022 Jan 21.

Article en En | MEDLINE | ID: mdl-35061149

Palabras clave

Clinical outcome assessments; FDA PRO guidance; Fit-for-purpose; Patient experience; Patient-reported outcome; Systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Patient Rep Outcomes Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google